Literature DB >> 32624103

Cardiometabolic Disease and Dysfunction Following Spinal Cord Injury: Origins and Guideline-Based Countermeasures.

Mark S Nash1, David R Gater2.   

Abstract

The risks and health hazards of the cardiometabolic syndrome (CMS) are commonly reported in persons with spinal cord injuries (SCIs) and disorders. Overweight/obesity, insulin resistance, hypertension, and dyslipidemia are highly prevalent after SCI. Both the CMS diagnosis and physical deconditioning worsen the prognosis for all-cause cardiovascular disease. Evidence suggests a role for physical activity to address these risks, although intense exercise may be required. A lifestyle plan incorporating both exercise and nutrition represents a preferred approach for health management. Improved surveillance for CMS risks and exercise and nutritional management are essential for the preservation of optimal health and independence.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cardiometabolic disease; Cardiovascular disease; Exercise; Nutrition; Pharmacotherapy; Spinal cord injuries

Mesh:

Year:  2020        PMID: 32624103     DOI: 10.1016/j.pmr.2020.04.005

Source DB:  PubMed          Journal:  Phys Med Rehabil Clin N Am        ISSN: 1047-9651            Impact factor:   1.784


  10 in total

1.  Energy expenditure and nutrient intake after spinal cord injury: a comprehensive review and practical recommendations.

Authors:  Gary J Farkas; Alicia Sneij; David W McMillan; Eduard Tiozzo; Mark S Nash; David R Gater
Journal:  Br J Nutr       Date:  2021-09-23       Impact factor: 4.125

Review 2.  Neurogenic Obesity-Induced Insulin Resistance and Type 2 Diabetes Mellitus in Chronic Spinal Cord Injury.

Authors:  Phillip S Gordon; Gary J Farkas; David R Gater
Journal:  Top Spinal Cord Inj Rehabil       Date:  2021

Review 3.  Dietetics After Spinal Cord Injury: Current Evidence and Future Perspectives.

Authors:  Gary J Farkas; Alicia Sneij; David R Gater
Journal:  Top Spinal Cord Inj Rehabil       Date:  2021

Review 4.  Pathophysiology of Neurogenic Obesity After Spinal Cord Injury.

Authors:  David R Gater; Gary J Farkas; Eduard Tiozzo
Journal:  Top Spinal Cord Inj Rehabil       Date:  2021

5.  Body Composition and Metabolic Assessment After Motor Complete Spinal Cord Injury: Development of a Clinically Relevant Equation to Estimate Body Fat.

Authors:  David R Gater; Gary J Farkas; David R Dolbow; Arthur Berg; Ashraf S Gorgey
Journal:  Top Spinal Cord Inj Rehabil       Date:  2021

6.  Influence of mid and low paraplegia on cardiorespiratory fitness and energy expenditure.

Authors:  Gary J Farkas; Phillip S Gordon; Ann M Swartz; Arthur S Berg; David R Gater
Journal:  Spinal Cord Ser Cases       Date:  2020-12-16

7.  Phase 1 Safety Trial of Autologous Human Schwann Cell Transplantation in Chronic Spinal Cord Injury.

Authors:  Katie L Gant; James D Guest; Anne E Palermo; Aditya Vedantam; George Jimsheleishvili; Mary Bartlett Bunge; Adriana E Brooks; Kim D Anderson; Christine K Thomas; Andrea J Santamaria; Monica A Perez; Rosie Curiel; Mark S Nash; Efrat Saraf-Lavi; Damien D Pearse; Eva Widerström-Noga; Aisha Khan; W Dalton Dietrich; Allan D Levi
Journal:  J Neurotrauma       Date:  2021-05-03       Impact factor: 4.869

8.  Evaluation of the Cardiometabolic Disorders after Spinal Cord Injury in Mice.

Authors:  Adel B Ghnenis; Calvin Jones; Arthur Sefiani; Ashley J Douthitt; Andrea J Reyna; Joseph M Rutkowski; Cédric G Geoffroy
Journal:  Biology (Basel)       Date:  2022-03-24

9.  Visceral Adiposity, Inflammation, and Testosterone Predict Skeletal Muscle Mitochondrial Mass and Activity in Chronic Spinal Cord Injury.

Authors:  Jacob A Goldsmith; Raymond E Lai; Ryan S Garten; Qun Chen; Edward J Lesnefsky; Robert A Perera; Ashraf S Gorgey
Journal:  Front Physiol       Date:  2022-02-10       Impact factor: 4.566

10.  Albumin knockout mice exhibit reduced plasma free fatty acid concentration and enhanced insulin sensitivity.

Authors:  Afsoun Abdollahi; Brianna N Dowden; Kimberly K Buhman; Alyssa S Zembroski; Gregory C Henderson
Journal:  Physiol Rep       Date:  2022-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.